Company intelligence / Profile preview

DoctorNow

Ownership: Private
Development stage: Commercial

Overview

DoctorNow operates a widely used telemedicine and digital health platform supporting online doctor consultations, medical advice, and hospital reservation services. The company has achieved significant adoption in South Korea with over 1.5 million cumulative uses and has expanded into Japan by establishing a Tokyo office in February 2024. It was recognized as a CES 2023 Innovation Award winner in Digital Health for its technology.

Therapeutic areas: OtherInfectious Diseases
Modalities: Non-pharmacological therapy
Industry: Non-Academic Healthcare

Partnerships

JETRO Invest Japan Business Support Center supported Japanese market entry

Beyond the preview

Go deeper on DoctorNow.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on DoctorNow.

Explore the full profile